These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31763757)

  • 1. Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Bayón J; Santás-Álvarez M; Ocaranza-Sánchez R; González-Juanatey C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E174-E176. PubMed ID: 31763757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.
    McCutcheon K; Bennett J; Marynissen T; Adriaenssens T
    Acta Cardiol; 2020 Feb; 75(1):85-86. PubMed ID: 30735472
    [No Abstract]   [Full Text] [Related]  

  • 3. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Tovar Forero MN; van Zandvoort L; Masdjedi K; Diletti R; Wilschut J; de Jaegere PP; Zijlstra F; Van Mieghem NM; Daemen J
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):226-231. PubMed ID: 31033171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.
    García-Guimaraes M; Antuña P; Cuesta J; Alfonso F
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):79-81. PubMed ID: 30244535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
    Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
    Hideo-Kajita A; Garcia-Garcia HM; Haude M; Joner M; Koolen J; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Teik LS; Escaned J; Azizi V; Kuku KO; Ozaki Y; Dan K; Waksman R
    Cardiovasc Revasc Med; 2019 May; 20(5):392-398. PubMed ID: 31079817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2015 May; 8(5):617-618. PubMed ID: 25457765
    [No Abstract]   [Full Text] [Related]  

  • 10. Restenosis in a Collapsed Magnesium Bioresorbable Scaffold.
    Barkholt TØ; Neghabat O; Terkelsen CJ; Christiansen EH; Holm NR
    Circ Cardiovasc Interv; 2017 Oct; 10(10):. PubMed ID: 29042399
    [No Abstract]   [Full Text] [Related]  

  • 11. Early collapse causing stenosis in a resorbable magnesium scaffold.
    Marynissen T; McCutcheon K; Bennett J
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):310-312. PubMed ID: 30019823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 13. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical Coherence Tomographic Image Pattern of Metallic Bioresorbable Vascular Scaffold Restenosis.
    Roa-Garrido J; Cardenal-Piris RM; El Amrawy AM; Gomez-Menchero A; Camacho Freire S; Diaz-Fernandez JF
    JACC Cardiovasc Interv; 2018 Apr; 11(7):707-708. PubMed ID: 29550091
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.
    Chang CC; Onuma Y; Achenbach S; Barbato E; Chevalier B; Cook S; Dudek D; Escaned J; Gori T; Kočka V; Tarantini G; West NEJ; Morice MC; Tijssen JGP; van Geuns RJ; Smits PC;
    Cardiovasc Revasc Med; 2019 Jul; 20(7):577-582. PubMed ID: 31153846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
    Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography Study.
    Ueki Y; Räber L; Otsuka T; Rai H; Losdat S; Windecker S; Garcia-Garcia HM; Landmesser U; Koolen J; Byrne R; Haude M; Joner M
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008657. PubMed ID: 32093514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study.
    Karjalainen P; Paana T; Sia J; Nammas W
    Cardiology; 2017; 137(4):225-230. PubMed ID: 28467998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.